Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma

Kaouther Snoussi, A. Donny Strosberg, Noureddine Bouaouina, Slim Ben Ahmed, Ahmed Noureddine Helal, Lotfi Chouchane

Research output: Contribution to journalArticle

101 Citations (Scopus)

Abstract

Background: Leptin (LEP) has been consistently associated with angiogenesis and tumor growth. Leptin exerts its physiological action through its specific receptor (LEPR). We have investigated whether genetic variations in LEP and LEPR have implications for susceptibility to and prognosis in breast carcinoma. Methods: We used the polymerase chain reaction and restriction enzyme digestion to characterize the variation of the LEP and LEPR genes in 308 unrelated Tunisian patients with breast carcinoma and 222 healthy control subjects. Associations of the clinicopathologic parameters and these genetic markers with the rates of the breast carcinoma-specific overall survival (OVS) and the disease free survival (DFS) were assessed using univariate and multivariate analyses. Results: A significantly in creased risk of breast carcinoma was associated with heterozygous LEP (-2548) GA (OR = 1.45; P = 0.04) and homozygous LEP (-2548) AA (OR = 3.17; P = 0.001) variants. A highly significant association was found between the heterozygous LEPR 223QR genotype (OR = 1.68; P = 0.007) or homozygous LEPR 223RR genotype (OR = 2.26; P = 0.001) and breast carcinoma. Moreover, the presence of the LEP (-2548) A allele showed a significant association with decreased disease-free survival in breast carcinoma patients, and the presence of the LEPR 223R allele showed a significant association with decreased overall survival. Conclusion: Our results indicated that the polymorphisms in LEP and LEPR genes are associated with increased breast cancer risk as well as disease progress, supporting our hypothesis for leptin involvement in cancer pathogenesis.

Original languageEnglish
Article number38
JournalBMC Cancer
Volume6
DOIs
Publication statusPublished - 20 Feb 2006
Externally publishedYes

Fingerprint

Leptin Receptors
Leptin
Breast Neoplasms
Disease-Free Survival
Alleles
Genotype
Breast Diseases
Survival
Genetic Markers
Genes
Digestion
Neoplasms
Healthy Volunteers
Multivariate Analysis
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Oncology
  • Genetics
  • Cancer Research

Cite this

Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma. / Snoussi, Kaouther; Strosberg, A. Donny; Bouaouina, Noureddine; Ahmed, Slim Ben; Helal, Ahmed Noureddine; Chouchane, Lotfi.

In: BMC Cancer, Vol. 6, 38, 20.02.2006.

Research output: Contribution to journalArticle

Snoussi, Kaouther ; Strosberg, A. Donny ; Bouaouina, Noureddine ; Ahmed, Slim Ben ; Helal, Ahmed Noureddine ; Chouchane, Lotfi. / Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma. In: BMC Cancer. 2006 ; Vol. 6.
@article{747ed8609d6746ba8fd063ea9cf59bac,
title = "Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma",
abstract = "Background: Leptin (LEP) has been consistently associated with angiogenesis and tumor growth. Leptin exerts its physiological action through its specific receptor (LEPR). We have investigated whether genetic variations in LEP and LEPR have implications for susceptibility to and prognosis in breast carcinoma. Methods: We used the polymerase chain reaction and restriction enzyme digestion to characterize the variation of the LEP and LEPR genes in 308 unrelated Tunisian patients with breast carcinoma and 222 healthy control subjects. Associations of the clinicopathologic parameters and these genetic markers with the rates of the breast carcinoma-specific overall survival (OVS) and the disease free survival (DFS) were assessed using univariate and multivariate analyses. Results: A significantly in creased risk of breast carcinoma was associated with heterozygous LEP (-2548) GA (OR = 1.45; P = 0.04) and homozygous LEP (-2548) AA (OR = 3.17; P = 0.001) variants. A highly significant association was found between the heterozygous LEPR 223QR genotype (OR = 1.68; P = 0.007) or homozygous LEPR 223RR genotype (OR = 2.26; P = 0.001) and breast carcinoma. Moreover, the presence of the LEP (-2548) A allele showed a significant association with decreased disease-free survival in breast carcinoma patients, and the presence of the LEPR 223R allele showed a significant association with decreased overall survival. Conclusion: Our results indicated that the polymorphisms in LEP and LEPR genes are associated with increased breast cancer risk as well as disease progress, supporting our hypothesis for leptin involvement in cancer pathogenesis.",
author = "Kaouther Snoussi and Strosberg, {A. Donny} and Noureddine Bouaouina and Ahmed, {Slim Ben} and Helal, {Ahmed Noureddine} and Lotfi Chouchane",
year = "2006",
month = "2",
day = "20",
doi = "10.1186/1471-2407-6-38",
language = "English",
volume = "6",
journal = "BMC Cancer",
issn = "1471-2407",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma

AU - Snoussi, Kaouther

AU - Strosberg, A. Donny

AU - Bouaouina, Noureddine

AU - Ahmed, Slim Ben

AU - Helal, Ahmed Noureddine

AU - Chouchane, Lotfi

PY - 2006/2/20

Y1 - 2006/2/20

N2 - Background: Leptin (LEP) has been consistently associated with angiogenesis and tumor growth. Leptin exerts its physiological action through its specific receptor (LEPR). We have investigated whether genetic variations in LEP and LEPR have implications for susceptibility to and prognosis in breast carcinoma. Methods: We used the polymerase chain reaction and restriction enzyme digestion to characterize the variation of the LEP and LEPR genes in 308 unrelated Tunisian patients with breast carcinoma and 222 healthy control subjects. Associations of the clinicopathologic parameters and these genetic markers with the rates of the breast carcinoma-specific overall survival (OVS) and the disease free survival (DFS) were assessed using univariate and multivariate analyses. Results: A significantly in creased risk of breast carcinoma was associated with heterozygous LEP (-2548) GA (OR = 1.45; P = 0.04) and homozygous LEP (-2548) AA (OR = 3.17; P = 0.001) variants. A highly significant association was found between the heterozygous LEPR 223QR genotype (OR = 1.68; P = 0.007) or homozygous LEPR 223RR genotype (OR = 2.26; P = 0.001) and breast carcinoma. Moreover, the presence of the LEP (-2548) A allele showed a significant association with decreased disease-free survival in breast carcinoma patients, and the presence of the LEPR 223R allele showed a significant association with decreased overall survival. Conclusion: Our results indicated that the polymorphisms in LEP and LEPR genes are associated with increased breast cancer risk as well as disease progress, supporting our hypothesis for leptin involvement in cancer pathogenesis.

AB - Background: Leptin (LEP) has been consistently associated with angiogenesis and tumor growth. Leptin exerts its physiological action through its specific receptor (LEPR). We have investigated whether genetic variations in LEP and LEPR have implications for susceptibility to and prognosis in breast carcinoma. Methods: We used the polymerase chain reaction and restriction enzyme digestion to characterize the variation of the LEP and LEPR genes in 308 unrelated Tunisian patients with breast carcinoma and 222 healthy control subjects. Associations of the clinicopathologic parameters and these genetic markers with the rates of the breast carcinoma-specific overall survival (OVS) and the disease free survival (DFS) were assessed using univariate and multivariate analyses. Results: A significantly in creased risk of breast carcinoma was associated with heterozygous LEP (-2548) GA (OR = 1.45; P = 0.04) and homozygous LEP (-2548) AA (OR = 3.17; P = 0.001) variants. A highly significant association was found between the heterozygous LEPR 223QR genotype (OR = 1.68; P = 0.007) or homozygous LEPR 223RR genotype (OR = 2.26; P = 0.001) and breast carcinoma. Moreover, the presence of the LEP (-2548) A allele showed a significant association with decreased disease-free survival in breast carcinoma patients, and the presence of the LEPR 223R allele showed a significant association with decreased overall survival. Conclusion: Our results indicated that the polymorphisms in LEP and LEPR genes are associated with increased breast cancer risk as well as disease progress, supporting our hypothesis for leptin involvement in cancer pathogenesis.

UR - http://www.scopus.com/inward/record.url?scp=33644883030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644883030&partnerID=8YFLogxK

U2 - 10.1186/1471-2407-6-38

DO - 10.1186/1471-2407-6-38

M3 - Article

VL - 6

JO - BMC Cancer

JF - BMC Cancer

SN - 1471-2407

M1 - 38

ER -